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Abstract The clinical and neuroanatomical correlates of
speciﬁc apraxias in neurodegenerative disease are not well
understood. Here we addressed this issue in progressive
nonﬂuent aphasia (PNFA), a canonical subtype of fronto-
temporal lobar degeneration that has been consistently
associated with apraxia of speech (AOS) and in some cases
orofacial apraxia, limb apraxia and/or parkinsonism. Six-
teen patients with PNFA according to current consensus
criteria were studied. Three patients had a corticobasal
syndrome (CBS) and two a progressive supranuclear palsy
(PSP) syndrome. Speech, orofacial and limb praxis func-
tions were assessed using the Apraxia Battery for Adults-2
and a voxel-based morphometry (VBM) analysis was
conducted on brain MRI scans from the patient cohort in
order to identify neuroanatomical correlates. All patients
had AOS based on reduced diadochokinetic rate, 69% of
cases had an abnormal orofacial apraxia score and 44% of
cases (including the three CBS cases and one case with
PSP) had an abnormal limb apraxia score. Severity of
orofacial apraxia (but not AOS or limb apraxia) correlated
with estimated clinical disease duration. The VBM analysis
identiﬁed distinct neuroanatomical bases for each form of
apraxia: the severity of AOS correlated with left posterior
inferior frontal lobe atrophy; orofacial apraxia with left
middle frontal, premotor and supplementary motor cortical
atrophy; and limb apraxia with left inferior parietal lobe
atrophy. Our ﬁndings show that apraxia of various kinds
can be a clinical issue in PNFA and demonstrate that
speciﬁc apraxias are clinically and anatomically dissocia-
ble within this population of patients.
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Introduction
Apraxia can be deﬁned as a higher order motor disorder of
skilled and/or learned movements [1]. The motor control
deﬁcit in apraxia may be speciﬁc for particular movements
or body parts: amongst these, apraxia of limb movements is
most often described, however apraxias of the cranial
musculature (orofacial apraxia: [2]) and apraxia of the
ﬁnely coordinated movements of articulation (apraxia of
speech, AOS: [3]) are also well recognised. The nature and
brain basis for these speciﬁc disorders of voluntary action
have not been fully deﬁned, and apraxia remains an issue
of considerable neurobiological as well as clinical interest.
Anatomical evidence, chieﬂy from patients with stroke, has
implicated distributed cerebral circuitry in the voluntary
control of orofacial and limb movements and the produc-
tion of apraxias [4, 5]: for orofacial apraxia, prefrontal
areas and their subcortical projections are particularly
implicated whilst for limb apraxia more posterior areas,
particularly the parietal lobe and its connections appear to
be most commonly involved [4, 5]. Aphasia (and in par-
ticular, impaired speech production) has often been docu-
mented in association with apraxia [5], and frontoparietal
circuits in the dominant hemisphere have also been
implicated in the programming of speech sounds and in
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insula and posterior left inferior frontal gyrus (‘Broca’s
area’) [6–9]. However, the relations between these differ-
ent forms of apraxia and their precise anatomical substrates
remain contentious.
Progressive nonﬂuent aphasia (PNFA) is a neurode-
generative disorder considered to be one of the primary
progressive aphasias (PPA) and falling within the fronto-
temporal lobar degeneration (FTLD) spectrum [10, 11].
Although the term PNFA was originally considered to
include all patients with progressively ‘‘nonﬂuent’’ speech
of any cause [5], some recent studies have limited PNFA to
include only those patients with motor speech impairment
and/or expressive agrammatism [12, 13]. In particular,
these studies have stressed the importance of apraxia of
speech (AOS) as a deﬁning feature of this group of patients
[14]: AOS is a motor speech disorder with the features of
hesitancy, effortfulness with articulatory groping, phonetic
errors and dysprosody [3, 15]. PNFA may be associated
clinically with parkinsonian syndromes, in particular either
a corticobasal degeneration syndrome (CBS) or a pro-
gressive supranuclear palsy (PSP) syndrome. At post
mortem, abnormal tau inclusions are often seen in PNFA,
with the 4-repeat tauopathies of corticobasal degeneration
or PSP common underlying pathologies [16, 17]. Limb
apraxia is a well-known feature of CBS [18] and can also
occur with PSP syndromes [19, 20]. Although less well
studied, orofacial apraxia may also develop in CBS [21,
22]. The clinico-pathological overlap of CBS and PSP with
PNFA, coupled with the central role of AOS in the PNFA
syndrome, suggests that apraxia of different kinds may be
clinically relevant in PNFA. Both orofacial (or buccofacial)
apraxia [23–27] and limb apraxia [28] have been reported
in PNFA, however these associations have not been studied
systematically. Furthermore, although AOS has been
associated with atrophy in the left frontal lobe and insula
[14, 16], the neuroanatomical correlates of the apraxias
accompanying focal dementia syndromes have not been
established. In this study, we assessed speech, orofacial and
limb praxis in a cohort of patients with PNFA and assessed
neuroanatomical correlates of the corresponding apraxis
using the semi-automated and unbiased technique of voxel-
based morphometry (VBM).
Methods
Sixteen patients with a diagnosis of PNFA according to
current consensus criteria [11, 12] were recruited from the
tertiary Specialist Cognitive Disorders Clinic of the
National Hospital of Neurology and Neurosurgery, Lon-
don, UK. The PNFA cohort comprised 12 men and 4
women with a mean (standard deviation) age at assessment
of 72.1 (?/-6.9) years and disease duration from symptom
onset of 5.8 (?/-2.1) years. Five patients had parkinsonian
features when assessed: three had CBS, and two PSP.
Research ethics approval for this study was obtained from
the National Hospital for Neurology and Neurosurgery and
University College London Hospitals Research Ethics
Committees.
Apraxia analysis
We used subscores from the Apraxia Battery for Adults-2
(ABA-2 [29]) as measures of apraxia. Diadochokinetic
(DDK) rate score (ABA-2 subtest 1) was measured by
asking patients to repeat the phrases ‘‘puh-tuh’’, ‘‘tuh-kuh’’,
‘‘puh-tuh-kuh’’ and ‘‘pluh-kruh-tuh’’ as many times as
possible in 3 s (for two syllable phrases) and 5 s (for three
syllable phrases) for a maximum of three trials, and the sum
of the best trials from each of the four phrases was used as
the total score. DDK rate for alternating syllables is par-
ticularly sensitive to the presence of AOS [30] and here is
used as a surrogate measure of AOS severity. Orofacial
apraxia score was based on ABA-2 subtest 3B in which
patients were asked to perform the following actions: stick
out your tongue, whistle, puff out your cheeks, pretend to
kiss, clear your throat, bite your lower lip, show me your
teeth, take a deep breath and hold it, lick your lips and open
your mouth. Each action was scored out of 5 (i.e., maximum
score was 50): a score of 5 was assigned when the subject
made an accurate, prompt, complete and readable gesture; 4
when the subject made an ambiguous or incorrect gesture,
but self corrected to an accurate response, 3 when the
subject’s gesture was essentially correct, but crude and
defective in amplitude, speed or accuracy. If the subject
made no response after ten seconds, or attempted a response
but was unsuccessful, the gesture was demonstrated by the
examiner and scores were assigned as follows: 2 when the
subject performed correctly after demonstration, 1 when the
subject’s gesture, after demonstration, was essentially cor-
rect, but crude and defective in amplitude, speed or accu-
racy, and 0 when, even after demonstration, the subject was
unable to perform the correct gesture. Limb apraxia score
was based on ABA-2 subtest 3A in which patients were
asked to perform the following gestures: make a ﬁst, wave
goodbye, snap your ﬁngers, throw a ball, hide your eyes,
make a hitch-hiking sign, make a pointing sign, salute, play
the piano and scratch. Scoring was as for orofacial praxis
with a maximum score of 50.
VBM analysis
MR brain images were acquired on a 1.5T GE Signa
scanner (General Electric, Milwaukee, WI). T1-weighted
volumetric images were obtained with a 24-cm ﬁeld of
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123view and 256 9 256 matrix to provide 124 contiguous 1.5-
mm-thick slices in the coronal plane (TE = 5 ms,
TR = 12 ms, TI = 650 ms). VBM was implemented using
SPM5 software (http://www.ﬁl.ion.ucl.ac.uk/spm) with
default settings for all parameters. Brain images underwent
an initial segmentation process in SPM5 which simulta-
neously estimated transformation parameters for warping
grey matter (GM), white matter (WM) and cerebrospinal
ﬂuid (CSF) tissue probability maps (TPMs) onto the ima-
ges. The native space GM segments were then rigidly
spatially normalised, using just the rotations and transla-
tions from the inverse of the TPM transformation, and
resampled to 1.5 mm isotropic resolution. These ‘‘impor-
ted’’ images were then iteratively warped to an evolving
estimate of their group-wise GM average template using
the DARTEL toolbox [31, 32]. The GM segmentations
were then normalised using the ﬁnal DARTEL transfor-
mations and modulated to account for volume changes.
Finally, the images were smoothed using a 6-mm full-
width at half-maximum (FWHM) Gaussian kernel. Linear
regression models were used to examine changes in GM
volume as functions of apraxia of speech (as measured by
diadochokinetic rate score, ABA-2 subtest 1), orofacial
apraxia (ABA-2 subtest 3B score) and limb apraxia (ABA-
2 subtest 3A score) across the PPA group. Voxel intensity,
V, was modelled as a function of praxis score, combining
scores for AOS and orofacial apraxia and separately for
each apraxia subtype, with subject age and total intracra-
nial volume (TIV) included as nuisance covariates. V = b1
apraxia ? b2 age ? b3 TIV ? l ? e (where l is a con-
stant, and e is error). The analysis was performed over
voxels inside a ‘consensus mask’ [33], which included all
voxels where intensity[0.1 was present in[70% of sub-
jects. Maps showing statistically signiﬁcant correlations
were generated, uncorrected at a 0.001 signiﬁcance
threshold. Statistical parametric maps were displayed as
overlays on a study-speciﬁc template, created by warping
all native space whole-brain images to the ﬁnal DARTEL
template and calculating the average of the warped brain
images.
Results
All patients scored in the abnormal range for DDK rate
(AOS): most (69%) scored in the mildly impaired range,
19% in the moderate range and 13% in the severe range
(Fig. 1a). For the orofacial apraxia measure, 69% of
patients (11 of 16) scored within the abnormal range (50%
mild, 13% moderate and 6% severe) (Fig. 1b). This
included all of the patients with either CBS or a PSP
syndrome. Patients without orofacial apraxia tended to be
those scoring in the mildly impaired range for DDK rate (4
of 5) with only one patient scoring normally but in the
moderately impaired range for DDK rate. A substantial
minority of PNFA patients had limb apraxia, 44% (7
patients) scoring in the abnormal range (Fig. 1c). These
seven cases included the three patients with CBS and one
of the patients with PSP; i.e. three patients with limb
apraxia did not have a CBS or PSP syndrome. For the
orofacial apraxia score there was a correlation with esti-
mated clinical disease duration (p = 0.04); no such cor-
relation was found for DDK rate score (p = 0.23) or limb
praxis (p = 0.38). Although we did not assess patients
Fig. 1 Diadochokinetic rate score (a), orofacial apraxia score (b) and limb apraxia score (c) as a function of disease duration. Mild, moderate
and severe score cut-offs (based on ABA-2 norms) are denoted by dotted lines
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123formally for the presence of swallowing apraxia, it is
noteworthy that none of the patients included in this study
reported clinical dysphagia.
In the VBM analysis, the combined praxis score for
AOS and orofacial apraxia correlated with grey matter in a
left premotor, dorsolateral and inferior frontal cortical
network. Distinct correlates of different forms of apraxia
were identiﬁed when scores were modelled separately.
Reduced DDK rate (AOS) correlated with grey matter loss
in the left posterior inferior frontal gyrus (pars opercularis
of Broca’s area, Brodmann area 45) (Fig. 2a). Orofacial
apraxia correlated with grey matter loss in the left middle
frontal gyrus (Brodmann area 46), and premotor and sup-
plementary motor areas (Fig. 2b). Limb apraxia correlated
with grey matter loss in the left inferior parietal lobe
(Brodmann area 40) (Fig. 2c).
Discussion
This study provides further conﬁrmation that PNFA is
associated with AOS, and reveals that orofacial apraxia
occurs in the majority of cases while limb apraxia occurs in
a substantial minority, particularly when there is an asso-
ciated parkinsonian syndrome. Clinically, these ﬁndings
suggest a need for some care in equating progressive
apraxia with a particular entity such as CBS, and indicate
the relevance of assessing patients presenting with PNFA
for deﬁcits in the programming of actions beyond speech
articulation. The ﬁndings further demonstrate speciﬁc
anatomical substrates for these different forms of apraxia in
PNFA: AOS was associated with posterior left inferior
frontal gyrus atrophy, orofacial apraxia was associated with
atrophy of left middle frontal and premotor cortices, while
limb apraxia was associated with more posterior atrophy in
the left parietal lobe.
Our ﬁndings corroborate previous work, mainly in
aphasic stroke, indicating that orofacial apraxia, often
though not invariably, accompanies AOS [8, 9, 30]. Ana-
tomically, AOS and orofacial apraxia in this neurodegen-
erative population showed critical substrates that were in
proximity (but non-identical) in these disorders. The
neuroanatomical correlates identiﬁed here are in keeping
with previous evidence [4, 9] and implicate separable
mechanisms for the programming of different kinds of
complex, learned actions in the left frontal lobe. Clinical
and anatomical distinctions between AOS and orofacial
apraxia are not absolute and may in part reﬂect different
kinds of actions as well as muscle groups involved in these
different forms of apraxia [5, 6]: AOS may represent a
deﬁcit of precise sequencing of orofacial and tongue
movements, while orofacial apraxia represents a deﬁcit in
the execution of discrete (and relatively crude) orofacial
actions. Orofacial apraxia may have a more distributed
Fig. 2 VBM analysis
correlating grey matter loss with
diadochokinetic rate (apraxia of
speech) score (a), orofacial
apraxia score (b) and limb
apraxia score (c). Statistical
parametric maps (SPMs) have
been thresholded at p\0.001
(uncorrected) and rendered on
coronal (left), axial (middle) and
sagittal (right) sections of a
study-speciﬁc average group
T1-weighted MRI template
image in DARTEL space. In
coronal and axial sections, the
left hemisphere (L) is shown on
the left side of the image as
indicated. All sagittal sections
are through the left hemisphere
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123anatomical basis, consistent with a more generic role in
orofacial motor control. Our ﬁnding that the development
of orofacial apraxia, but not AOS or limb apraxia, corre-
lates with disease duration may speak to the anatomical
organisation of these functions: strategic damage involving
relatively focal cortical modules may be sufﬁcient to pro-
duce AOS or limb apraxia, while the more distributed
control of relatively simple orofacial movements implies
greater neural redundancy but may be correspondingly
more vulnerable to cumulative cortical insults with the
advancing neurodegenerative process.
Consistent with a large body of clinical observation,
we found that limb apraxia was associated with CBS [34–
36], however this association was not clinically speciﬁc:
individual patients with PNFA and no associated parkin-
sonian features nevertheless exhibited limb apraxia.
Anatomically, and in accord with previous anatomical
evidence [34–36], limb apraxia was associated with left
parietal lobe atrophy. It may be that limb apraxia is an
early sign of the development of a parkinsonian syn-
drome, consistent with previous suggestions of a close
pathophysiological relation between these deﬁcits [5];
longitudinal studies of PNFA cohorts will be required to
resolve this issue. A further unsettled issue concerns the
histopathological substrate for limb apraxia and for the
other speciﬁc apraxias studied here, and in particular, any
speciﬁcity for tau versus non-tau inclusions: it has been
proposed that AOS (and indeed PNFA more generally) is
closely associated with tau pathology, in particular corti-
cobasal degeneration and PSP [17]. This is a further
important issue for future longitudinal studies with post
mortem correlation.
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